fashion -WSS

fashion

author：focus 2025-09-02 05:51:49 - browse：6

Stacks of silver coins surrounded by a medicare health insurance card — insurance coverage from STAT — A federal rule that could make Medicare reimbursement for breakthrough devices easier is slated for early summer. Adobe

WASHINGTON — A federal rule aiming to make reimbursement for breakthrough devices easier is slated for early summer, a Centers for Medicare and Medicaid Services official said on Thursday.

The agency has faced intense pressure from device makers frustrated with the slow pace of Medicare reimbursement decisions. Medical technology lobby AdvaMed sent CMS a strongly-worded letter in March asking why it has taken so long to get the breakthrough device program moving.

Dora Hughes, director of the clinical standards center at CMS, told attendees at the Medical Device Manufacturers’ Association conference the agency wanted to take the time to meaningfully address feedback sent during the comment period, which closed in August. She also noted the organization’s goal of releasing the final rule with a slate of other policies, including a rule clarifying the agency’s thinking on what kind of evidence would be needed to convince the agency that a given device is both reasonable and necessary.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Cancer, immunology, HIV research ensnared in fetal tissue politics

focus

WSS

What Kate Middleton's cancer revelation might teach the world

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Yancopoulos of Regeneron works to expand Dupixent success

Readout Newsletter: Beam, Prozac, "TechBio" and more

6 surprising facts about sugar

U.K. officials, researchers try to ease path for bespoke genetic treatments

knowledge

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

Moonlake's readout produced a cash windfall. Risks remain

Doctor of U.S. President Joe Biden says he is fit for duty

Heart attack and stroke risk calculators need revising

Virtual repurposing can help discover new uses for existing drugs

After affirmative action ruling, medical educators look to 'holistic review'

This gene therapy has record $4.25 million price. It's saved children.

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Asbestos ban is immediate, but health effects will linger for decades

State Dept. review finds Biden bears some blame for Afghanistan failures

Biotech investment managers search for lucrative opportunities

knowledge

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Asbestos ban is immediate, but health effects will linger for decades

6 surprising facts about sugar

Doctor of U.S. President Joe Biden says he is fit for duty

Mirador, a new biotech startup, launches with $400 million

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

entertainment

knowledge

focus

focus